Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Report Date
Kopp Leroy CN/A735,0001.05%2000-08-22
Edward O. Lanphier,IIPresident & CEO235,0000.34%2015-07-15
John W. LarsonDirector214,6600.31%2015-01-05
Mr. H. Ward WolffExec VP & CFO197,8720.28%2015-07-10
Dr. Geoffrey M. NicholN/A138,1460.2%2014-12-11
Peter BlufordVP, Corporate Development135,7910.19%2004-10-04
Dr. Philip D. Gregory,D.Phil.SVP of Research & CSO116,4100.17%2015-06-01
Dr. Dale G. Ando,M.D.VP, Therapeutic Dev. & CMO96,7630.14%2015-06-05
Dr. William G. Gerber,M.D.N/A68,3000.1%2007-12-06
David IchikawaSenior VP, Bus. Dev.25,000less than 0.1%2011-12-08

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
(Click for the stocks that their CEOs have bought)
2015-07-15Sell25,0001,420,521$10.43260.8-30.11235,000 (Direct)
1,185,521 (By Trust)
Wolff Henry WardExec VP & CFO2015-07-13Sell12,000197,872$10120-27.1197,872 (Direct)
LANPHIER EDWARD O IIPresident & CEO2015-06-15Sell25,0001,420,521$11.08277-34.21235,000 (Direct)
1,185,521 (By Trust)
Wolff Henry WardExec VP & CFO2015-06-10Sell12,000199,872$12.21146.5-40.29199,872 (Direct)
ANDO DALE GVP, Therapeutic Dev. & CMO2015-06-05Sell15,00096,763$12.29184.4-40.6896,763 (Direct)
RINGO WILLIAM RDirector2015-06-03Sell2,200800$12.4427.4-41.4800 (Direct)
Gregory Philip DSVP of Research & CSO2015-06-01Sell15,000116,410$12.39185.9-41.16116,410 (Direct)
LANPHIER EDWARD O IIPresident & CEO2015-05-15Sell25,0001,420,521$11.51287.8-36.66235,000 (Direct)
1,185,521 (By Trust)
Wolff Henry WardExec VP & CFO2015-05-11Sell12,000201,872$13.25159-44.98201,872 (Direct)
ANDO DALE GVP, Therapeutic Dev. & CMO2015-05-05Sell15,00095,376$12.29184.4-40.6895,376 (Direct)
RINGO WILLIAM RDirector2015-05-04Sell3,000800$12.9838.9-43.84800 (Direct)
Gregory Philip DSVP of Research & CSO2015-05-01Sell15,000116,410$12.62189.3-42.23116,410 (Direct)
LANPHIER EDWARD O IIPresident & CEO2015-04-15Sell25,0001,420,521$15.33383.3-52.45235,000 (Direct)
1,185,521 (By Trust)
Wolff Henry WardExec VP & CFO2015-04-10Sell12,000202,849$15.31183.7-52.38202,849 (Direct)
ANDO DALE GVP, Therapeutic Dev. & CMO2015-04-06Sell15,00095,376$14.94224.1-51.295,376 (Direct)
RINGO WILLIAM RDirector2015-04-06Sell2,200800$14.9532.9-51.24800 (Direct)
Gregory Philip DSVP of Research & CSO2015-04-01Sell15,000116,410$15.15227.3-51.88116,410 (Direct)
Wolff Henry WardExec VP & CFO2015-03-19Sell10,000204,849$18180-59.5204,849 (Direct)
LANPHIER EDWARD O IIPresident & CEO2015-03-16Sell25,0001,420,521$17.29432.3-57.84235,000 (Direct)
1,185,521 (By Trust)
Wolff Henry WardExec VP & CFO2015-03-10Sell12,000204,849$16.68200.2-56.29204,849 (Direct)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership